Skip to main content

Advertisement

Table 5 Tumor control and survival of the patients in the TME and CCRT + TME groups

From: Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial

Group 3-year rate (%) Local recurrence (cases [%]) Distant metastasis (cases [%])
DFS OS
TME 85.7 90.7 4 (4.3) 12 (12.8)
CCRT + TME 87.9 92.3 4 (4.4) 9 (10.0)
P 0.766 0.855 0.776 0.834